VXX-401, a novel anti-PCSK9 vaccine, reduces LDL-C in cynomolgus monkeys
-
Published:2024-02
Issue:2
Volume:65
Page:100497
-
ISSN:0022-2275
-
Container-title:Journal of Lipid Research
-
language:en
-
Short-container-title:Journal of Lipid Research
Author:
Vroom Madeline M.ORCID,
Lu Hanxin,
Lewis Maggie,
Thibodeaux Brett A.,
Brooks Jeanne K.,
Longo Matthew S.,
Ramos Martina M.ORCID,
Sahni JayaORCID,
Wiggins Jonathan,
Boyd Justin D.,
Wang Shixia,
Ding Shuang,
Hellerstein Michael,
Ryan Valorie,
Powchik Peter,
Dodart Jean-Cosme
Reference49 articles.
1. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019;Abbafati;Lancet,2020
2. LDL-C target attainment in secondary prevention of ASCVD in the United States: barriers, consequences of nonachievement, and strategies to reach goals;Underberg;Postgrad. Med.,2022
3. Antibody-based therapeutics for atherosclerosis and cardiovascular diseases;Ji;Int. J. Mol. Sci.,2021
4. Foam cells in atherosclerosis: novel insights into its origins, consequences, and molecular mechanisms;Gui;Front. Cardiovasc. Med.,2022
5. Macrophages and foam cells: brief overview of their role, linkage, and targeting potential in atherosclerosis;Poznyak;Biomedicines,2021
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献